Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.19B | 30.50B | 27.32B | 25.79B | 23.35B | 20.27B |
Gross Profit | 4.37B | 4.26B | 4.47B | 5.06B | 4.88B | 3.50B |
EBITDA | 1.84B | 1.50B | 2.08B | 2.69B | 2.55B | 1.55B |
Net Income | 1.09B | 880.15M | 1.26B | 1.74B | 1.62B | 934.82M |
Balance Sheet | ||||||
Total Assets | 29.95B | 31.29B | 26.85B | 27.43B | 24.44B | 20.56B |
Cash, Cash Equivalents and Short-Term Investments | 6.45B | 7.25B | 6.87B | 4.79B | 5.49B | 5.54B |
Total Debt | 17.64B | 18.67B | 14.63B | 15.64B | 13.40B | 11.18B |
Total Liabilities | 18.76B | 19.79B | 15.77B | 17.12B | 15.21B | 12.46B |
Stockholders Equity | 11.19B | 11.49B | 11.08B | 10.30B | 9.23B | 8.10B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.11B | 3.57B | -2.34B | -1.56B | 1.00B |
Operating Cash Flow | 0.00 | -1.60B | 4.55B | -706.53M | -1.28B | 2.75B |
Investing Cash Flow | 0.00 | -1.62B | -1.25B | -1.55B | -434.60M | -1.75B |
Financing Cash Flow | 0.00 | 3.54B | -1.50B | 1.58B | 1.67B | 905.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥9.71B | 51.80 | 3.98% | 0.43% | -91.24% | ||
72 Outperform | ¥9.41B | 10.24 | 5.54% | 11.64% | -30.52% | ||
71 Outperform | ¥8.64B | 4.28 | 1.74% | 6.93% | 63.17% | ||
68 Neutral | ¥9.32B | 4.85 | 3.05% | 13.64% | 128.96% | ||
66 Neutral | ¥7.12B | 27.06 | ― | 341.55% | -0.36% | ||
64 Neutral | $7.01B | 18.92 | -1.36% | 6.84% | 4.67% | -25.39% | |
53 Neutral | ¥6.71B | 114.71 | ― | 42.72% | -110.19% |